Poly Medicure Ltd

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date perspective on its performance and outlook.

Poly Medicure Ltd, a small-cap player in the Healthcare Services sector, has seen a marked shift in its valuation parameters, moving from an already expensive rating to a very expensive one. This change, coupled with its recent market performance and peer comparisons, raises important questions about the stock’s price attractiveness for investors amid evolving market dynamics.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Poly Medicure Ltd, a small-cap player in the Healthcare Services sector, has exhibited a notable shift in its technical parameters, moving from a bearish to a mildly bearish trend. Despite a recent day gain of 1.90%, the stock’s technical indicators present a complex picture, with some suggesting cautious optimism while others maintain a bearish outlook. This article analyses the latest momentum, technical signals, and comparative performance to provide a comprehensive view for investors.

The Sensex declined by 1.92% on 1 Apr 2026, while Poly Medicure Ltd surged 7.38%, outperforming its Healthcare Services sector by 0.44 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment.

Poly Medicure Ltd commenced trading on 1 April 2026 with a significant gap up, opening 5.05% higher than its previous close. This strong start reflects a positive market sentiment despite the stock’s ongoing technical challenges and a recent downgrade in its mojo rating.

While the broader market showed signs of recovery, Poly Medicure Ltd slipped to a fresh 52-week low of Rs 1,190.7 on 30 Mar 2026, extending its recent downtrend amid sectoral and company-specific pressures.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

For the fifth consecutive session, Poly Medicure Ltd closed lower, slipping to a fresh 52-week low of Rs 1203.7 on 23 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper than its sector peers and the benchmark indices.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Poly Medicure Ltd demonstrated robust intraday strength on 4 Mar 2026, surging to a day’s high of Rs 1,407.8, marking a 7.77% increase from its previous close. This performance outpaced the broader Healthcare Services sector and the Sensex, reflecting notable trading momentum amid a mixed market backdrop.

Poly Medicure Ltd, a key player in the Healthcare Services sector, touched a fresh 52-week low of Rs.1210.35 today, marking a significant decline in its stock price amid ongoing challenges in both near-term and long-term performance metrics.

Poly Medicure Ltd’s shares declined to a fresh 52-week low of Rs.1240 on 27 Feb 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The healthcare services company has witnessed a sustained fall in its share price, reflecting a combination of subdued financial performance and broader market pressures.

Poly Medicure Ltd, a key player in the Healthcare Services sector, touched a new 52-week low of Rs.1242.25 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance factors.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.